Subscribe To Our Free Newsletter |
Mankind Pharma to raise Rs 10,000 crore through NCDs, CPs to fund BSV deal
The company will raise up to Rs 5,000 crore through non-convertible debentures (NCDs) maturing in up to 48 months, according to a regulatory filing.